Both in Biotechnology
Armata Pharmaceuticals vs Humacyte
Over the past year ARMP returned −35.1% and HUMA returned −69.2%; their daily moves had a correlation of 0.14.
ARMP −35.1% HUMA −69.2%Growth of $1, one year, split-adjusted
| Metric | ARMP | HUMA |
|---|---|---|
| Price | $3.14 | $0.4500 |
| Market cap | $116.8M | $125.0M |
| Today | +1.62% | +2.16% |
| 1 month | −18.4% | −5.9% |
| 6 months | −65.3% | −54.2% |
| Year to date | −50.0% | −53.1% |
| 1 year | −35.0% | −71.7% |
| Revenue growth (YoY) | +15.7% | +34.9% |
| Gross margin | 100.0% | −203.2% |
| Net margin | 2953.8% | −9064.5% |
| P/E (TTM) | — | — |
| Price / sales | 21.1× | 58.9× |
| Net cash | -$259.6M | $13.7M |
| Dividend yield | — | — |
| Volatility (60d) | 114.9% | 107.9% |
| Short % of float | 4.4% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).